PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
"Early-stage breast cancer patients undergoing radiation therapy following breast-conserving surgery experienced significantly less skin irritation when they used a melatonin-containing cream compared
Continue readingA new study called “Decision Making about Surgery for Early-Stage Breast Cancer” finds that the women studied had major deficits in their knowledge about the pros and cons of having either
Continue reading… clearly shows that black women have a much higher rate of heart failure after a breast cancer diagnosis than do other ethnic groups… As a cancer survivor who has sustained cardiovascular
Continue readingOncotype DX for Breast Cancer- Ductal Carcinoma In-situ (DCIS) is Not Breast Cancer-Consider Evidence-based, Non-Toxic Therapies to Reduce Your Risk of Breast Cancer The mission of PeopleBeatingCancer
Continue readingReduce your Pre-Malignant DCIS from becoming Full-Blown Breast Cancer You’ve been diagnosed with Ductal Carcinoma In-Situ (DCIS). While some people will call this diagnosis breast cancer, it really
Continue readingThe finding may mean that (breast cancer patients) women with pain related to aromatase inhibitor use might stick to their meds longer if acupuncture eases their joint pain. Aromatase inhibitors are a
Continue readingThey did not just publish that the breast cancer cure rates were the same, but they published very in-depth cosmetic assessments Breast Cancer can be complicated. The two guiding principles of PeopleBeatingCancer
Continue readingReduce your risk of Breast Cancer and/or your Risk of Breast Cancer relapse through evidence-based, non-toxic therapy I am not a BC survivor. I am a survivor of a blood cancer called multiple myeloma.
Continue reading“That means we can use 50 times less of the drug and still get the same results…Paclitaxel is a potent drug used in the United States as a first- and second-line treatment for breast…” Hi
Continue readingA new study suggests that “an estimated 20 percent of breast cancer patients in the United States who receive radiation after they undergo breast-conserving surgery may not have their radiation treatments
Continue reading“When we compare our low-dose tamoxifen data with results from the… trials of tamoxifen given at 20 mg per day, we see comparable risk reduction and significantly reduced serious adverse events,
Continue readingFrom 2013 to 2015, keeping other factors constant, chemotherapy use (for breast cancer) was estimated to decline from 34.5% to 21.3%. A diagnosis of cancer is difficult, to say the least. However, an
Continue reading